Welsh, Carson, Anderson & Stowe

What is Welsh, Carson, Anderson & Stowe?

Welsh, Carson, Anderson & Stowe (WCAS) is a private equity firm with a primary focus on the technology and healthcare sectors. With over 45 years of experience and having raised over $40 billion across 18 funds, WCAS holds a reputation for forming enduring partnerships with leading management teams across their investment areas.

They operate with a clear mandate to drive growth through guiding sustainable organic growth strategies, cultivating top talent and company culture, and leveraging technological evolution to unlock new market potential. They also maintain a rigorous approach to M&A, evaluating and sourcing prime targets.

Their portfolio covers a broad range of subsectors including Data & Information Services, EdTech, FinTech, GovTech, Government, Risk and Compliance, HCM, Payments, Real Estate, Supply Chain Management (SCM), Care Delivery, Healthcare IT (HCIT), MedTech, Payor Services & Risk-Based Care, and Pharma Value Chain.

WCAS is committed to investing in better healthcare and supporting innovation in technology, aiming to be the partner of choice.

The firm specializes in transactions such as Management Buyouts (MBO)/Leveraged Buyouts (LBO), Acquisition Financing, Recapitalization, Restructuring, Special Situations, and Going Private transactions. With an investment range between $100 million and $600 million, WCAS caters to mid to large-sized businesses, directing their comprehensive expertise and financial resources toward facilitating businesses' market leadership aspirations.

Their assets under management are reported to be around $27 billion, signifying a significant capacity for deploying capital in their designated areas of expertise. Furthermore, WCAS emphasizes Environmental, Social, and Governance (ESG) & Diversity and Inclusion (D&I) in their investment philosophy, instilling responsible investing practices as they strive for generating formidable returns for their investors.